galanin(1-19) (human) [3541]



galanin(1-19) (human)


SMILES CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)C(C)C
InChIKey UKPCKEWJIIKMHQ-WNXXINOUSA-N
Sequence GWTLNSAGYLLGPHAVGNH
HELM PEPTIDE1{G.W.T.L.N.S.A.G.Y.L.L.G.P.H.A.V.G.N.H}$$$$

Chemical Properties

Hydrogen bond acceptors 27
Hydrogen bond donors 27
Rotatable bonds 57
Log P -8.282
Molecular weight (Da) 1963.0
Stereochemistry info partial

Database connections

Model (AF2) GAL1

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

galanin(1-19) (human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) GAL1

Compound is not listed as a drug.